Pattern of and clinicopathologic risk factors for lateral lymph node metastases in papillary thyroid carcinoma patients with lateral cervical lymphadenopathy
Authors:
Open Access
- 1 September 2018
- journal article
- research article
- Published by Wolters Kluwer Health in Medicine
- Vol. 97 (36) , e12263
Abstract
The surgical extension of lateral neck dissection (LND) in papillary thyroid carcinoma (PTC) with clinical lateral lymph node metastases (LLNM) remains controversial. The aim of this study was to explore the pattern of and clinicopathologic risk factors for LLNM in PTC with clinical unilateral LND to determine the rational extent of therapeutic LND. This retrospective study reviewed the records of 246 consecutive patients with PTC who simultaneously underwent total thyroidectomy, bilateral central lymph node dissection, and unilateral therapeutic LND. The frequency and pattern of LLNM were analyzed. Grossly, LLNM were present in 80.9% of patients, and level II to V lymph node metastases (LNM) were present in 45.9%, 62.6%, 56.1%, and 11.8% patients, respectively. Superior tumor location, extrathyroidal extension, and ipsilateral, contralateral, and bilateral central LNM (CLNM) were independent risk factors for gross LLNM. Age >= 45 years, superior lobe tumors, extrathyroidal extension, and ipsilateral and contralateral CLNM were independent risk factors for level II LNM. Age >= 45 years, superior and middle lobe tumors, extrathyroidal extension, and ipsilateral CLNM were independent risk factors for level III LNM. Superior lobe tumors and ipsilateral, contralateral, and bilateral CLNM were independent risk factors for level IV LNM. Only contralateral CLNM was an independent risk factor for level V LNM. In PTC patients with clinical LLNM, the predominant sites of LLNM were levels II to IV and not level V. Therapeutic elective LND should include the lateral nodal levels associated with independent risk factors, especially superior tumors location and CLNM.Keywords
This publication has 37 references indexed in Scilit:
- Should level V be included in lateral neck dissection in treating papillary thyroid carcinoma?World Journal of Surgical Oncology, 2013
- Preoperative detection and predictors of level V lymph node metastasis in patients with papillary thyroid carcinomaBritish Journal of Surgery, 2012
- Optimal surgical extent of lateral and central neck dissection for papillary thyroid carcinoma located in one lobe with clinical lateral lymph node metastasisWorld Journal of Surgical Oncology, 2012
- Metastatic papillary thyroid cancer with lateral neck disease: Pattern of spread by levelHead & Neck, 2012
- American Thyroid Association Consensus Review and Statement Regarding the Anatomy, Terminology, and Rationale for Lateral Neck Dissection in Differentiated Thyroid CancerThyroid®, 2012
- Pattern and predictive factors of regional lymph node metastasis in papillary thyroid carcinoma: A prospective studyHead & Neck, 2012
- What is the appropriate extent of lateral neck dissection in the treatment of metastatic well‐differentiated thyroid carcinoma?The Laryngoscope, 2010
- Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid CancerThyroid®, 2009
- Predictors of level V metastasis in well‐differentiated thyroid cancerHead & Neck, 2008
- Lateral Cervical Lymph Node Metastases from Papillary Thyroid Carcinoma: Pattern of Nodal Metastases and Optimal Strategy for Neck DissectionAnnals of Surgical Oncology, 2008